Stay updated on Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added a dedicated Locations section listing Indiana as a study site. The Indiana Locations item was removed and the revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T07:32:45.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2; no visible content changes detected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:15:27.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.1 was added and v3.2.0 was removed from the page's revision history. This is a metadata update with no changes to the study content.
    Difference
    0.1%
    Check dated 2025-11-24T11:11:49.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    Removed a banner stating potential information delays due to a lapse in government funding and links to operating-status pages (cc.nih.gov and opm.gov).
    Difference
    0.4%
    Check dated 2025-11-17T06:12:31.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    No additions or deletions detected. The page content remains the same and continues to present the study details.
    Difference
    0.5%
    Check dated 2025-11-03T00:46:47.000Z thumbnail image
  9. Check
    92 days ago
    Change Detected
    Summary
    Overall, the page updates to announce a system status notice and a new software version (v3.2.0), removing the previous v3.1.0 reference.
    Difference
    3%
    Check dated 2025-10-05T07:26:33.000Z thumbnail image

Stay in the know with updates to Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial page.